Epitomics: Global profiling of immune response to disease using protein microarrays

OMICS A Journal of Integrative Biology

Volumn 10, Issue 4, 2006, Pages 499-506

  Chatterjee, Madhumita ^a   Ionan, Alexei ^a   Draghici, Sorin ^a,b   Tainsky, Michael A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b Wayne State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; EPITOPE; PROTEIN; TUMOR PROTEIN;

AUTOIMMUNE DISEASE; BIOMEDICINE; BIOSENSOR; BIOTECHNOLOGY; CANCER DIAGNOSIS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; EPITOMICS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL MEMORY; IMMUNOTHERAPY; INFECTION; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; METHODOLOGY; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN MICROARRAY; REVIEW; SENSITIVITY AND SPECIFICITY; SERUM; TECHNIQUE; TREATMENT PLANNING;

EPITOPES; HUMANS; IMMUNE SYSTEM; PROTEIN ARRAY ANALYSIS;

EID: 33846633730     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2006.10.499     Document Type: Review

References (25)

1. BOON, T., and VAN DER BRUGGEN, P. (1996). Human tumor antigens recognized by T lymphocytes. J Exp Med 183, 725-729.
2. CAREY, V. (2004). ROC: utilities for ROC, with uarray focus. R package, Version 1.0.13. Available from: http://www.bioconductor.org.
3. CHATTERJEE, M., DRAGHICI, S., and TAINSKY, MA. (2006a). Immunotheranostics: breaking tolerance in immunotherapy using tumor autoantigens identified on microarrays. Curr Opin Drug Disc Dev 9, 380-385.
4. CHATTERJEE, M., MOHAPATRA, S., IONAN, A., BAWA, G., ALI-FEHMI, R., WANG, X., et al. (2006b) Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 66, 1181-1190.
5. CHEN, Y.T., SCANLAN, M.J., SAHIN, U., TURECI, O., GURE, A.O., and TSANG, S. (1997). A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94, 1914-1918.
6. CHOI, S.H., PARK, E.Y., JUNG, H.L., SHIM, J.W., KIM, D.S., PARK, M.S., et al. (2006). Serum vascular endothelial growth factor in pediatric patients with community- accquired pneumonia and pleural effusion. J Korean Med Sci 22, 608-613.
7. DISIS, M.L., CALENOFF, E., MCLAUGHLIN, G., MURPHY, A.E., CHEN, W., GRONER, B., et al. (1994). Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res 54, 16-20.
8. DISIS, M.L., KNUTSON, K.L., SCHIFFMAN, K., RINN, K., and MCNEEL, D.G. (2000). Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer. Breast Cancer Res Treat 62, 245-252.
9. DISIS, M.L., PUPA, S.M., GRALOW, J.R., DITTADI, R., MENARD, S., and CHEEVER, M.A. (1997). High-liter HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer. J Clin Oncol 15, 3363-3367.
10. DODD, L.E., and PEPE, M.S. (2003). Partial AUC estimation and regression. Biometrics 59, 614-623.
11. DRAGHICI, S., CHATTERJEE, M., and TAINSKY, M.A. (2005). Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens. Expert Rev Mol Diag 5, 735-743.
12. EFRON, B., and TIBSHIRANI, R.J. (1993). An introduction to the bootstrap. (Chapman & Hall, New York).
13. FARILLA, L., TIBERTI, C., LUZZAGO, A., YU, L., EISENBARTH, G.S., and CORTESE, R. (2002). Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes. Eur J Immunol 32, 1420-1427.
14. MEWAR, D., MOORE, D.J., YOUNG-MIN, S., BERTOLACCINI, M.L., KHAMASHTA, M.A., Watson, P.F., et al. (2005). Antiferritin antibodies discovered by phage display expression cloning are associated with radiographic damage in rheumatoid arthritis. Arthritis Rheum 52, 3868-3872.
15. NAORA, H., YANG, Y.Q., MONTZ, F.J., SEIDMAN, J.D., KURMAN, R.J., and RODEN, R.B. (2001). A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. Proc Natl Acad Sci USA 98, 4060-4065.
16. OGUZKAN, S., TERZI, Y.K., CINBIS, M., ANLAR, B., AYSUN, S., and AYTER, S. (2006). Molecular genetic analyses in neurofibromatosis type 1 patients with tumors. Cancer Genet Cytogenet 165, 167-171.
17. PEPE, M.S., LONGTON, G., ANDERSON, G.L., and SCHUMMER, M. (2003). Selecting differentially expressed genes from microarray experiments. Biometrics 59, 133-142.
18. R DEVELOPMENT CORE TEAM (2004). R: a language and environment for statistical computing. (www. R-project.org. R Foundation for Statistical Computing, Vienna, Austria.
19. ROSENBERG, A., GRIFFIN, K., STUDIER, F.W., MCORMICK, M., BERG, J., and NOVY, R. (1996). T7 select phage display system: a powerful new protein display system based on bacteriophage T7. inNovations 6, 1-6.
20. SAHIN, U., TURECI, O., and PFREUNDSCHUH, M. (1997). Serological identification of human tumor antigens. Curr Opin Immunol 9, 709-716.
21. SAHIN, U., TURECI, O., SCHMITT, H., COCHLOVIUS, B., JOHANNES, T., SCHMITS, R., et al. (1995). Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92, 11810-11813.
22. SOMERS, V., GOVARTS, C., HELLINGS, N., HUPPERTS, R., and STINISSEN, P. (2005). Profiling the autoantibody repertoire by serological antigen selection. J Autoimmunol 25, 223-228.
23. STEVENSON, V.L., and THOMPSON, A.J. (1998). The management of multiple sclerosis: current and future therapies. Drugs Today (Barc.) 34, 267-282.
24. STOCKERT, E., JAGER, E., CHEN, Y.T., SCANLAN, M.J., GOUT, I., KARBACH, J., et al. (1998). A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 187, 1349-1354.
25. VOGL, F.D., FREY, M., KREIENBERG, R., and RUNNEBAUM, I.E. (2000). Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass. Br J Cancer 83, 1338-1343.